# China NMPA Drug Inspection - Jiangsu Hengrui Medicine Co., Ltd - Irritoxib tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jiangsu-hengrui-medicine-co-ltd/96b612f8-0960-4844-bd86-852e374ce318/
Source feed: China

> China NMPA drug inspection for Jiangsu Hengrui Medicine Co., Ltd published July 28, 2022. Drug: Irritoxib tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Jiangsu Hengrui Medicine Co., Ltd
- Publication Date: 2022-07-28
- Drug Name: Irritoxib tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/jiangsu-hengrui-medicine-co-ltd/c1c549bd-a137-40c4-8e02-cf0d607c7c15/